Ex-Harvard postdoc sues university for drug royalties
By 
Rebecca Trager2017-05-12T14:32:00
Former Harvard chemist says he lost out on millions after the technology he worked on was licensed to Merck & Co
A chemist who worked as a postdoctoral researcher at Harvard from 2011 to 2015 has sued the university, arguing that he was unfairly excluded as an inventor on a long-time project and thereby lost out on royalty payments. Alexander Arefolov’s lawsuit claims that nearly $6 million (£4.7 million) was paid to the other listed inventors.